Neuromodulation Devices Market Size 2022 Global Opportunities, Trends, Share, Regional Overview, Global Growth, And Country Forecast to 2027

 

Neuromodulation Devices Market

The global neuromodulation devices market is accruing pervasively. Market growth attributes to the increasing prevalence of neurological disorders, such as chronic pain, dystonia, Parkinson's disease, epilepsy, and other psychological disorders. Furthermore, injuries such as traumatic brain injury, multiple sclerosis, stroke, and brain tumors, alongside the neurological (central nervous system) damage, provide impetus to market growth.

According to Market Research Future (MRFR), the global Neuromodulation Devices Market is poised to grow at 11.2% CAGR during the forecast period (2017-2023). The emergence of robotics is considered as one of the key forces driving the market growth to an extent. Neuromodulation devices have evolved dramatically over the past few years, fostering active engagement in neuromodulation and robotics. With each stage, the market size of these devices has grown, too, seeing augmented demand & uptake.

Neuromodulation Devices Market – Segments

The report is segmented into five dynamics;

·         By Type: Internal Neuromodulation and External Neuromodulation (non-invasive).

·         By Application: Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), and Gastric Electrical Stimulation (GES), and others.

·         By Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and others.

·         By End-User: Hospitals, Clinics, Homecare, and others.

·         By Regions: Europe, North America, APAC, and the Rest-of-the-World.

Major Players: 

Players leading the global neuromodulation devices market include LivaNova PLC (UK), St. Jude Medical, Inc. (US), Boston Scientific Corporation (US), Bioness Inc. (US), Aleva Neurotherapeutics SA (US), EnteroMedics Inc (US), NeuroPace Inc. (US), Nevro Corporation (US), Synapse Biomedical, Inc. (US), Neuronetics, Inc. (US), Neurosigma, Inc. (US), Cyberonics, Inc. (US), Accellent (US), BioControl Medical (Israel), DynaMD (US), and Soterix Medical, Inc. (US), among others.

Global Neuromodulation Devices Market – Geographical Analysis

North America dominates the global neuromodulation devices market. The region accounted for around 55% of the overall market share in 2017. The largest market share attributes to the surging product and technology developments. Besides, the increase in awareness among people and the high prevalence of neurological conditions such as epilepsy, chronic pain, and Parkinson's disease drive market growth. The North American neuromodulation devices market is expected to retain its dominance throughout the review period.

Europe stands second in the global neuromodulation devices market. The market is driven by the increase in the prevalence of neurological disorders.  Technological advancements, coupled with the increasing incidences of neurological disorders and the presence of well-established healthcare infrastructures, boost the regional market growth. Additionally, the growing awareness of the advantages of neuromodulation devices drives market growth in the region.

Favorable governmental support and initiatives push the growth in the regional market. Besides, the proliferating healthcare sector and the resurging economy is fostering the regional market growth radiantly. Germany, among other European countries, leads the market in the region. The European neuromodulation devices market is expected to grow at a considerable CAGR during the forecast period.

The neurorehabilitation devices market in the Asia Pacific region is growing briskly. Factors such as the growing introduction of new and better neuromodulation devices and the increasing prevalence of neurological disorders drive regional market growth. Besides, the vast development opportunities and the continually developing healthcare infrastructure in the APAC region, propel market growth.

Countries like India, China & Japan account for the wide adoption of these devices, which, in turn, drives the market growth in the region. China holds a significant share in the regional market due to its large manufacturing base, large population, economic development, and booming internal demand. India accounts for the second-largest share in the regional market due to rising healthcare expenditures and growing awareness regarding mental disorders.

Global Neuromodulation Devices Market – Competitive Analysis 

Highly competitive, the global neuromodulation devices market appears fragmented due to the presence of several well-established players. These players initiate strategies such as mergers & acquisitions, collaborations, expansion, and technology launch to gain a larger competitive advantage. Industry players invest substantially in R&D and clinical trials to develop efficient medical devices. Market players collaborate with academia to the biotech industry, which contributes specialized knowledge and cutting-edge technologies to accelerate innovations. Collaborations form one of the pillars of these companies' innovation strategies.

Industry/Innovation/Related News:

·         July 23, 2020 ---- Abbott Laboratories (the US), a multinational medical device and healthcare company, announced receiving the US FDA approval for its iOS-Compatible App, replacing neuromodulation system controllers. The new App allows people living with chronic pain and movement disorders to personalize therapy via their mobile device. Apple smartphone-compatible, digital health tool aligns within the company's comprehensive NeuroSphere™ Digital Care connected care management platform, which is developed to optimize care for chronic pain and movement disorders.

·         With this app approval, the need to carry a separate patient programmer device is eliminated, streamlining the patient's experience and seamlessly integrating therapy management into their life. This is an essential step in the integration and connection of digital health tools that ultimately help patients live fuller, healthier lives.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

 

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more